GW Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.04.21	GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation (GlobeNewswire)
20.04.21	Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's secured notes; negative outlook (Moodys)
20.04.21	GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex (GlobeNewswire)
09.04.21	Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's new secured credit facilities; negative outlook (Moodys)
28.02.21	Februar 2021: Analysten sehen Potenzial bei GW Pharmaceuticals-Aktie (finanzen.net)
26.02.21	GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis Complex (GlobeNewswire)
04.02.21	Jazz Securities Designated Activity Company -- Moody's reviews Jazz Pharma's ratings for downgrade (Moodys)
04.02.21	BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies (RTTNews)
03.02.21	MÄRKTE USA/Erholung verliert an Fahrt - Alphabet-Aktie mit Rekordhoch (Dow Jones)
03.02.21	MÄRKTE USA/Erholungsrally geht mit moderatem Tempo weiter (Dow Jones)
03.02.21	Stock Alert: GW Pharma Surges 50% As Jazz Pharma To Takeover The Co. (RTTNews)
03.02.21	MÄRKTE USA/Technologiewerte führen Börse weiter nach oben (Dow Jones)
03.02.21	MÄRKTE USA/Technologiewerte dürften Börse weiter nach oben führen (Dow Jones)
03.02.21	Jazz Pharma To Acquire GW Pharmaceuticals For $7.2 Bln - Quick Facts (RTTNews)
24.12.20	Canopy Growth Files Patent Infringement Lawsuit Against GW Pharmaceuticals (RTTNews)
03.11.20	Stock Alert: GW Pharmaceuticals Climbs 10% On Narrower Q3 Loss (RTTNews)
02.11.20	Ausblick: GW Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
05.08.20	Ausblick: GW Pharmaceuticals zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
04.08.20	ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. (RTTNews)
26.06.20	Biotech Stocks Facing FDA Decision In July 2020 (RTTNews)
24.06.20	GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug (GlobeNewswire)
10.05.20	Ausblick: GW Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
26.04.20	Erste Schätzungen: GW Pharmaceuticals präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
02.03.20	GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer (GlobeNewswire)
29.02.20	GW Pharmaceuticals-Aktie: Experten empfehlen GW Pharmaceuticals im Februar mehrheitlich zum Kauf (finanzen.net)
11.11.19	GW Pharma Receives Positive NICE Recommendation For EPIDYOLEX Oral Solution (RTTNews)
11.11.19	GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEX® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
24.09.19	European Union Approves First Cannabis-based Medicine Epidyolex (RTTNews)
23.09.19	GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
07.08.19	Guardant In Good Health, GW Pharma On Track, FLXN Abuzz (RTTNews)
04.08.19	Ausblick: GW Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
26.07.19	GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy (GlobeNewswire)
07.05.19	MÄRKTE USA/Handelskonflikt drückt Dow um über 470 Punkte (Dow Jones)
07.05.19	US-NACHBÖRSE/Mosaic nach Zahlenausweis schwach - Kurssprung bei AIG (Dow Jones)
04.05.19	Ausblick: GW Pharmaceuticals gewährt Anlegern Blick in die Bücher (finanzen.net)
25.11.18	Ausblick: GW Pharmaceuticals legt Quartalsergebnis vor (finanzen.net)
28.08.18	GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology (GlobeNewswire)
26.06.18	FDA Approves 1st Cannabis-Based Drug, TECH Opens Wallet Again, MACK, SPHS Plunge (RTTNews)
23.06.18	An Ear To The Pharma: 15 Stocks To Watch (AKAO, PTIE, ASNS…) (RTTNews)
29.05.18	Biotech Stocks Facing FDA Decision In June (RTTNews)
21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
20.04.18	ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN (RTTNews)
18.04.18	GWPH Faces FDA Panel Today, NVCR Reports STELLAR Data, 1st XLH Drug Cleared (RTTNews)
14.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...) (RTTNews)
05.04.18	KWHCoin Announces Partnership to Become the Largest Renewable Energy Blockchain in Puerto Rico (PR Newswire)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
25.02.18	An Ear To The Pharma: 6 Stocks To Watch This Week (RTTNews)
22.02.18	ACIP Backs HEPLISAV-B, GMED Hits New High, GWPH's Focal Seizures Trial Fails (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	88.94	7.57 %	K V
ABB	51.08	2.16 %	K V
CieFinRichemont	174.65	1.42 %	K V
Novartis	93.44	1.08 %	K V
Zurich Insur Gr	558.60	1.05 %	K V
Nestle	78.28	0.13 %	K V
Sika	231.80	-0.34 %	K V
Sonova Hldg	317.00	-0.47 %	K V
Givaudan	3’983.00	-1.02 %	K V
Lonza Grp	579.00	-2.62 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu GW Pharmaceuticals PLC American Deposit Share Repr 12 Shs

Aktien Top/Flop

Meistgelesene Nachrichten